Valuation Laboratorios Richmond S.A.C.I.F.

Stocks

End-of-day quote Buenos Aires S.E. 16/09/2026			5-day change	1st Jan Change
1,550.00 ^ARS	-0.96%		-2.21%	-21.52%

08-06	Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-11	Laboratorios Richmond S.A.C.I.F. announces Annual dividend, payable on May 15, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	9,327	17,927	31,412	56,405	144,949	159,484
Change	-	92.21%	75.23%	79.56%	156.98%	10.03%
Enterprise Value (EV) ¹	10,516	22,242	50,309	149,735	278,596	390,519
Change	-	111.5%	126.19%	197.63%	86.06%	40.17%
P/E	19.2x	30.3x	193x	-5.2x	6.08x	51.6x
PBR	2.76x	3.39x	3.11x	2.5x	2.25x	1.74x
PEG	-	1.4x	-2.7x	0x	-0x	-0.6x
Capitalization / Revenue	1.51x	1.08x	1.7x	1.45x	1.58x	1.26x
EV / Revenue	1.7x	1.34x	2.72x	3.84x	3.04x	3.08x
EV / EBITDA	6.66x	8.95x	15.1x	23.2x	15.3x	11.8x
EV / EBIT	7.07x	9.58x	16.9x	28.3x	17.9x	13.1x
EV / FCF	-27.8x	-9.98x	-5.19x	58x	-49x	-7.4x
FCF Yield	-3.59%	-10%	-19.3%	1.72%	-2.04%	-13.5%
Dividend per Share ²	0.5547	-	-	-	26.89	-
Rate of return	0.48%	-	-	-	1.5%	-
EPS ²	6.02	7.32	2.02	-134.4	295.3	38.24
Distribution rate	9.21%	-	-	-	9.11%	-
Net sales ¹	6,181	16,616	18,470	39,028	91,794	126,726
EBITDA ¹	1,578	2,486	3,326	6,441	18,249	32,999
EBIT ¹	1,487	2,322	2,982	5,299	15,565	29,906
Net income ¹	486.2	591.5	163.4	-10,851	23,845	3,088
Net Debt ¹	1,189	4,315	18,897	93,330	133,647	231,035
Reference price ²	115.50	222.00	389.00	698.50	1,795.00	1,975.00
Nbr of stocks (in thousands)	80,751	80,751	80,751	80,751	80,751	80,751
Announcement Date	10/03/21	09/03/22	09/03/23	11/03/24	07/03/25	06/03/26

¹ARS in Million²ARS

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LABORATORIOS RICHMOND S.A.C.I.F.	-	-	-	-	83.82M
ELI LILLY AND COMPANY	32.3x	11.75x	23.82x	0.61%	1,013B
JOHNSON & JOHNSON	29.72x	6.61x	18.51x	2.01%	644B
ABBVIE INC.	33.26x	7.79x	16.1x	2.61%	465B
ROCHE HOLDING AG	19.53x	4.77x	11.83x	2.78%	352B
NOVARTIS AG	19.64x	5.13x	12.73x	3.13%	264B
ASTRAZENECA PLC	20.94x	4.32x	12.33x	2.04%	253B
AMGEN INC.	23.76x	6.28x	11.19x	2.69%	203B
NOVO NORDISK A/S	12.28x	4.47x	9.35x	4.09%	188B
GILEAD SCIENCES, INC.	-44.25x	6.45x	25.21x	2.25%	181B
Average	16.35x	6.40x	15.67x	2.47%	356.38B
Weighted average by Cap.	23.51x	7.63x	17.62x	2.01%